133 related articles for article (PubMed ID: 16091733)
21. Proteinase-activated receptors 1 and 2 in rat olfactory system: layer-specific regulation of multiple signaling pathways in the main olfactory bulb and induction of neurite retraction in olfactory sensory neurons.
Olianas MC; Dedoni S; Onali P
Neuroscience; 2007 May; 146(3):1289-301. PubMed ID: 17434682
[TBL] [Abstract][Full Text] [Related]
22. The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway.
Ward Y; Yap SF; Ravichandran V; Matsumura F; Ito M; Spinelli B; Kelly K
J Cell Biol; 2002 Apr; 157(2):291-302. PubMed ID: 11956230
[TBL] [Abstract][Full Text] [Related]
23. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
[TBL] [Abstract][Full Text] [Related]
24. Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of rho- and Ca2+-dependent signaling pathways.
Seminario-Vidal L; Kreda S; Jones L; O'Neal W; Trejo J; Boucher RC; Lazarowski ER
J Biol Chem; 2009 Jul; 284(31):20638-48. PubMed ID: 19439413
[TBL] [Abstract][Full Text] [Related]
25. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling.
Stam JC; Michiels F; van der Kammen RA; Moolenaar WH; Collard JG
EMBO J; 1998 Jul; 17(14):4066-74. PubMed ID: 9670021
[TBL] [Abstract][Full Text] [Related]
26. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes.
Sorensen SD; Nicole O; Peavy RD; Montoya LM; Lee CJ; Murphy TJ; Traynelis SF; Hepler JR
Mol Pharmacol; 2003 Nov; 64(5):1199-209. PubMed ID: 14573770
[TBL] [Abstract][Full Text] [Related]
27. Beta-casein-derived peptides, produced by bacteria, stimulate cancer cell invasion and motility.
Oliveira MJ; Van Damme J; Lauwaet T; De Corte V; De Bruyne G; Verschraegen G; Vaneechoutte M; Goethals M; Ahmadian MR; Müller O; Vandekerckhove J; Mareel M; Leroy A
EMBO J; 2003 Nov; 22(22):6161-73. PubMed ID: 14609961
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.
Salhia B; Rutten F; Nakada M; Beaudry C; Berens M; Kwan A; Rutka JT
Cancer Res; 2005 Oct; 65(19):8792-800. PubMed ID: 16204049
[TBL] [Abstract][Full Text] [Related]
29. Targeting RhoA/Rho kinase and p21-activated kinase signaling to prevent cancer development and progression.
Chang YW; Bean RR; Jakobi R
Recent Pat Anticancer Drug Discov; 2009 Jun; 4(2):110-24. PubMed ID: 19519534
[TBL] [Abstract][Full Text] [Related]
30. [Effects of RhoA/Rho-kinase in the regulation of penile erection].
Xia C; Jiang R
Zhonghua Nan Ke Xue; 2007 Jun; 13(6):546-9. PubMed ID: 17615983
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts.
Nguyen QD; Rodrigues S; Rodrigue CM; Rivat C; Grijelmo C; Bruyneel E; Emami S; Attoub S; Gespach C
Mol Cancer Ther; 2006 Aug; 5(8):2070-7. PubMed ID: 16928828
[TBL] [Abstract][Full Text] [Related]
32. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
33. The Rho-kinase inhibitor Y-27632 and the soluble guanylyl cyclase activator BAY41-2272 relax rabbit vaginal wall and clitoral corpus cavernosum.
Cellek S
Br J Pharmacol; 2003 Jan; 138(2):287-90. PubMed ID: 12540518
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
Turcotte S; Desrosiers RR; Beliveau R
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
[TBL] [Abstract][Full Text] [Related]
35. RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction.
Tahara M; Morishige K; Sawada K; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
Endocrinology; 2002 Mar; 143(3):920-9. PubMed ID: 11861513
[TBL] [Abstract][Full Text] [Related]
36. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
[TBL] [Abstract][Full Text] [Related]
37. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
Watts VL; Motley ED
Exp Biol Med (Maywood); 2009 Feb; 234(2):132-9. PubMed ID: 19064940
[TBL] [Abstract][Full Text] [Related]
38. cGMP-enhancing- and alpha1A/alpha1D-adrenoceptor blockade-derived inhibition of Rho-kinase by KMUP-1 provides optimal prostate relaxation and epithelial cell anti-proliferation efficacy.
Liu CM; Lo YC; Wu BN; Wu WJ; Chou YH; Huang CH; An LM; Chen IJ
Prostate; 2007 Sep; 67(13):1397-410. PubMed ID: 17639498
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
40. Caveolae are required for protease-selective signaling by protease-activated receptor-1.
Russo A; Soh UJ; Paing MM; Arora P; Trejo J
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6393-7. PubMed ID: 19332793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
